
Validea's Benjamin Graham 'Value Investor' model assigned Intuitive Surgical (ISRG) a 71% rating, falling short of the 80% threshold for typical strategy interest. While ISRG, a large-cap growth stock, passed fundamental criteria including long-term EPS growth and low debt, its high P/E and Price/Book ratios, which are central to Graham's deep value methodology, prevented a higher score. This indicates that despite strong underlying fundamentals, ISRG's current valuation makes it less appealing from a strict deep value investment perspective.
Intuitive Surgical (ISRG) presents a classic conflict between strong operational fundamentals and a rich valuation, according to a Validea analysis using Benjamin Graham's deep value model. The company received a score of 71%, falling short of the 80% threshold that typically indicates strategist interest. ISRG, a large-cap growth stock, successfully passed key financial health checks, including criteria for sales, current ratio, low long-term debt relative to net current assets, and solid long-term EPS growth. However, it failed on the two core valuation metrics central to the Graham methodology: its Price-to-Earnings (P/E) and Price-to-Book (P/B) ratios are too high. This indicates that while the underlying business demonstrates robust health and growth, its current market price does not offer the margin of safety sought by a strict deep value investment philosophy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment